| ISIN | CH1244681594 |
|---|---|
| Valor Number | 124468159 |
| Bloomberg Global ID | CHDIV SW |
| Fund Name | UBS ETF (CH) - UBS MSCI Swiss Dividend ETF CHF dis |
| Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Fund Management (Switzerland) AG |
| Representative in Switzerland | |
| Distributor(s) | |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 13.96 CHF | 16.01.2026 |
|---|---|---|
| Previous Price * | 13.96 CHF | 15.01.2026 |
| 52 Week High * | 14.01 CHF | 20.03.2025 |
| 52 Week Low * | 11.95 CHF | 09.04.2025 |
| NAV * | 13.96 CHF | 16.01.2026 |
| Issue Price * | 13.96 CHF | 16.01.2026 |
| Redemption Price * | 13.96 CHF | 16.01.2026 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 51,261,312 | |
| Unit/Share Assets *** | 46,684,197 | |
| Trading Information SIX | ||
| YTD Performance | +1.63% |
31.12.2025 - 16.01.2026
31.12.2025 16.01.2026 |
|---|---|---|
| 1 month | +3.53% |
16.12.2025 - 16.01.2026
16.12.2025 16.01.2026 |
| 3 months | +5.40% |
16.10.2025 - 16.01.2026
16.10.2025 16.01.2026 |
| 6 months | +7.08% |
16.07.2025 - 16.01.2026
16.07.2025 16.01.2026 |
| 1 year | +12.70% |
16.01.2025 - 16.01.2026
16.01.2025 16.01.2026 |
| 2 years | +13.17% |
16.01.2024 - 16.01.2026
16.01.2024 16.01.2026 |
| 3 years | +16.67% |
13.04.2023 - 16.01.2026
13.04.2023 16.01.2026 |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 16.76% | |
|---|---|---|
| Novartis AG Registered Shares | 15.50% | |
| Zurich Insurance Group AG | 14.19% | |
| Nestle SA | 13.15% | |
| Swiss Re AG | 11.79% | |
| Partners Group Holding AG | 9.42% | |
| Helvetia Baloise Holding AG | 6.48% | |
| SGS AG | 6.45% | |
| Swisscom AG | 6.20% | |
| Kuehne + Nagel International AG | 3.53% | |
| Last data update | 13.01.2026 | |
| TER | 0.12% |
|---|---|
| TER date | 15.10.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.60% |
| Ongoing Charges *** | 0.20% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |